The Dubai Future Solutions – Prototypes for Humanity initiative is advancing three university ventures from Switzerland, the United States, and Egypt into pilot deployment and commercial expansion in the UAE, signaling a move from research to real-world deployment.

The first cohort features Oxara (low-CO2 construction materials), P-Vita (AI-driven agricultural biotechnology), and Virufy (AI-powered respiratory health screening), each progressing from pilots to commercial-scale deployment with international expansion plans.

The programme provides funding, business expertise, dedicated support teams, and industry collaborations to translate research into commercially viable solutions and to de-risk and accelerate growth to attract larger partners and investors.

Applications are open for the next Dubai Future Solutions summit in November, inviting graduates, students, and researchers to join the global showcase and compete for the 2027 ventures programme.

The programme is a major annual Dubai-based initiative under the patronage of Sheikha Latifa bint Mohammed and is a collaboration among the Dubai Future Foundation, DIFC, Art Dubai, and the Hussain Sajwani–DAMAC Foundation, bringing together around 100 startups from leading universities worldwide.

New ventures for the next cycle include teams from Harvard, Imperial College London, Petronas Technology University, and Duke University, with late-2026 conversations to advance deployments in the UAE.

P-Vita develops AI-driven, proprietary agricultural inputs and biotechnologies to address global shortages, with UAE trials and expansion to scale for thousands of smallholder farmers.

Virufy is building an AI-powered respiratory screening tool based on cough analysis, currently piloting with Dubai Health and aiming to scale to benefit developing nations.

Oxara turns mineral and construction waste into low-CO2 building materials, having completed a Dubai pilot with a major concrete manufacturer and pursuing Europe and Africa partnerships for scale.

The initiative emphasizes a de-risked, end-to-end pathway from lab to real-world deployment, fostering partnerships with government, industry, and capital.